154 related articles for article (PubMed ID: 12832322)
1. Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy.
Perseghin G; Caumo A; Arcelloni C; Benedini S; Lanzi R; Pagliato E; Sereni LP; Testolin G; Battezzati A; Comi G; Comola M; Luzi L
Diabetes Care; 2003 Jul; 26(7):2112-8. PubMed ID: 12832322
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between insulin secretion and insulin resistance in nondiabetic subjects with myotonic dystrophy--a case control study].
Goto T; Sato T; Hinata T; Suga S; Onuma T; Matsunaga M; Takebe K
No To Shinkei; 1995 Mar; 47(3):251-4. PubMed ID: 7669426
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.
Fernández-Real JM; Molina A; Broch M; Ricart W; Gutiérrez C; Casamitjana R; Vendrell J; Soler J; Gómez-Sáez JM
Diabetes; 1999 May; 48(5):1108-12. PubMed ID: 10331417
[TBL] [Abstract][Full Text] [Related]
4. The direct relationship of proinsulin-insulin hypersecretion to basal serum levels of cholesterol and triglyceride in myotonic dystrophy.
Poffenbarger PL; Bozefsky T; Soeldner JS
J Lab Clin Med; 1976 Mar; 87(3):384-96. PubMed ID: 765416
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance in myotonic dystrophy.
Piccardo MG; Pacini G; Rosa M; Vichi R
Enzyme; 1991; 45(1-2):14-22. PubMed ID: 1806362
[TBL] [Abstract][Full Text] [Related]
6. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.
Mari A; Pacini G; Murphy E; Ludvik B; Nolan JJ
Diabetes Care; 2001 Mar; 24(3):539-48. PubMed ID: 11289482
[TBL] [Abstract][Full Text] [Related]
7. Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults.
Vauhkonen I; Niskanen L; Knip M; Mykkänen LM; Haffner S; Uusitupa M; Laakso M
Eur J Endocrinol; 2005 Aug; 153(2):265-73. PubMed ID: 16061833
[TBL] [Abstract][Full Text] [Related]
8. Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes.
Nagi DK; Knowler WC; Mohamed-Ali V; Bennett PH; Yudkin JS
Diabetes Care; 1998 Jan; 21(1):127-33. PubMed ID: 9538983
[TBL] [Abstract][Full Text] [Related]
9. Hyperamylinemia is associated with hyperinsulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican-American non-insulin-dependent diabetic parents.
Gulli G; Rossetti L; DeFronzo RA
Metabolism; 1997 Oct; 46(10):1157-61. PubMed ID: 9322799
[TBL] [Abstract][Full Text] [Related]
10. Insulin regulation of leptin synthesis and secretion in humans: the model of myotonic dystrophy.
Gómez JM; Molina A; Fernández-Castañer M; Casamitjana R; Martínez-Matos JA; Soler J
Clin Endocrinol (Oxf); 1999 May; 50(5):569-75. PubMed ID: 10468921
[TBL] [Abstract][Full Text] [Related]
11. Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes.
Vauhkonen IK; Niskanen LK; Mykkänen L; Haffner SM; Uusitupa MI; Laakso M
Eur J Endocrinol; 2000 Aug; 143(2):251-60. PubMed ID: 10913945
[TBL] [Abstract][Full Text] [Related]
12. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
[TBL] [Abstract][Full Text] [Related]
13. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight.
Volk A; Renn W; Overkamp D; Mehnert B; Maerker E; Jacob S; Balletshofer B; Häring HU; Rett K
Exp Clin Endocrinol Diabetes; 1999; 107(2):140-7. PubMed ID: 10320055
[TBL] [Abstract][Full Text] [Related]
14. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
[TBL] [Abstract][Full Text] [Related]
15. Hyperproinsulinaemia in patients with myotonic dystrophy.
Krentz AJ; Clark PM; Cox L; Williams AC; Nattrass M
Diabetologia; 1992 Dec; 35(12):1170-2. PubMed ID: 1478370
[TBL] [Abstract][Full Text] [Related]
16. Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study.
Perseghin G; Ghosh S; Gerow K; Shulman GI
Diabetes; 1997 Jun; 46(6):1001-9. PubMed ID: 9166672
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men.
Zethelius B; Hales CN; Lithell HO; Berne C
Diabetes Care; 2004 Jun; 27(6):1433-8. PubMed ID: 15161800
[TBL] [Abstract][Full Text] [Related]
18. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.
van Haeften TW; Dubbeldam S; Zonderland ML; Erkelens DW
Diabetes Care; 1998 Feb; 21(2):278-82. PubMed ID: 9539996
[TBL] [Abstract][Full Text] [Related]
19. The role of insulin resistance in the pathogenesis of myotonic muscular dystrophy.
Hudson AJ; Huff MW; Wright CG; Silver MM; Lo TC; Banerjee D
Brain; 1987 Apr; 110 ( Pt 2)():469-88. PubMed ID: 3552109
[TBL] [Abstract][Full Text] [Related]
20. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.
Anderwald C; Anderwald-Stadler M; Promintzer M; Prager G; Mandl M; Nowotny P; Bischof MG; Wolzt M; Ludvik B; Kästenbauer T; Pacini G; Luger A; Krebs M
Diabetes Care; 2007 Sep; 30(9):2374-80. PubMed ID: 17595351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
